Clinical Trial Update: Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating safety, tolerability, and efficacy of switching from quetiapine to ziprasidone in schizophrenia and schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)
• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2010-02-02